BCG May 23, 2019
Sanjay Saxena , Ashish Kaura , Daniel Gorlin , and Jon Kaplan

It’s a vast market—projected to reach more than $360 billion a year by 2023—with attractive growth baked in. Below the surface, though, lie difficult dynamics and increasingly tough competition. Medicare Advantage—the insurance programs that private companies offer through Medicare—has established itself as a hot market segment that shows no signs of cooling, and lots of health care payers are eyeing it. But they should look carefully before they leap. Large incumbents such as United Health, Humana, CVS Aetna, and Anthem, along with powerful regional players such as WellCare, have built strong defenses. New entrants must develop a compelling value case if they are to gain a foothold, much less seize significant share. Here’s what companies...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Medicare Advantage, Payer
Medicare Advantage Enrollees Use Less Home Health Care In Their Final Days Than Traditional Medicare Patients
Medicare Advantage insurers ranked by prior authorization denial rates | 2023
Why Yale New Haven is having 'frank conversations' about MA
Medicare Advantage insurers made about 50 million prior authorization determinations in 2023
Cigna's Medicare Advantage sale on track to close in Q1

Share This Article